Mangoceuticals Inc. (MGRX): Price and Financial Metrics

Mangoceuticals Inc. (MGRX): $0.44

0.03 (+7.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add MGRX to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#54 of 70

in industry

MGRX Price/Volume Stats

Current price $0.44 52-week high $2.38
Prev. close $0.41 52-week low $0.14
Day low $0.37 Volume 1,916,300
Day high $0.46 Avg. volume 3,501,023
50-day MA $0.27 Dividend yield N/A
200-day MA $0.51 Market Cap 10.92M

MGRX Stock Price Chart Interactive Chart >



MGRX Latest News Stream


Event/Time News Detail
Loading, please wait...

MGRX Latest Social Stream


Loading social stream, please wait...

View Full MGRX Social Stream

Latest MGRX News From Around the Web

Below are the latest news stories about MANGOCEUTICALS INC that investors may wish to consider to help them evaluate MGRX as an investment opportunity.

FSLR Stock Alert: First Solar Scores New ‘Buy’ Rating

First Solar stock is rising on Friday as investors in FSLR react to a new "buy" rating and $211 price target from Jefferies.

William White on InvestorPlace | December 15, 2023

General Motors Layoffs: What to Know About the Latest GM Job Cuts

General Motors layoffs have the automobile company planning to cut roughly 1,300 jobs following the start of the new year.

William White on InvestorPlace | December 15, 2023

Why Is Mangoceuticals (MGRX) Stock Down 33% Today?

Mangoceuticals stock is falling on Friday after the company put into effect a public offering for shares of MGRX.

William White on InvestorPlace | December 15, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today!

William White on InvestorPlace | December 15, 2023

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Dallas, Texas, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (“GROW”) and erectile dysfunction (“ED”) drug (“Mango”), today priced its previously announced underwritten public offering of 4,000,000 shares of its common stock, par value $0.0001 per shar

Yahoo | December 15, 2023

Read More 'MGRX' Stories Here

MGRX Price Returns

1-mo 68.26%
3-mo 93.58%
6-mo -35.77%
1-year -59.63%
3-year N/A
5-year N/A
YTD 58.90%
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!